Sustained virological response to peginterferon therapy in patients infected with HCV (genotypes 2 and 3), with or without HIV. [electronic resource]
- BMC infectious diseases 2014
- S4 p. digital
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
1471-2334
10.1186/1471-2334-14-S5-S4 doi
Adult Aged Antiviral Agents--therapeutic use Coinfection--drug therapy Female Genotype HIV Infections--drug therapy HIV-1--physiology Hepacivirus--drug effects Hepatitis C--drug therapy Humans Interferon-alpha--therapeutic use Male Middle Aged Polyethylene Glycols--therapeutic use Recombinant Proteins--therapeutic use Retrospective Studies Ribavirin--therapeutic use Treatment Outcome Viral Load